| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.24 | 2e-08 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.086 | 0.06 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.092 | 0.06 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.082 | 0.08 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.08 | 0.08 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.061 | 0.2 |